Clinical Trial Update: A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study of methotrexate for chronic idiopathic urticaria, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Barnsley Hospital | Conditions: Urticaria | Phase 2 | Status: TERMINATED